10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Crinetics Pharmaceuticals Inc. (CRNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 8,338,098 | $302,839,719 | +21% | 1.73% |
| 2. | Driehaus Capital Richard Driehaus | 6,395,922 | $232,299,887 | +1% | 1.71% |
| 3. | EcoR1 Capital Oleg Nodelman | 4,288,120 | $155,744,518 | 6.61% | |
| 4. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,351,465 | $85,405,209 | +43% | 0.49% |
| 5. | Siren L.L.C. Raymond Debbane | 1,903,636 | $69,140,060 | +27% | 1.92% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.06 | 5,000 | $110,300.00 | 5,000 | 2023-06-08 | Filing | |
| $22.22 | 157,515 | $3,499,983.30 | 5,321,032 | 2022-04-18 | Filing | |
| $19.80 | 1,200,000 | $23,760,000.00 | 5,163,517 | 2021-10-25 | Filing | |
| $16.44 | 304,136 | $4,999,995.84 | 3,963,517 | 2021-04-08 | Filing | |
| $13.10 | 4,000 | $52,400.00 | 4,000 | 2020-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.10 | 85,163 | $3,415,036.30 | 105,289 | 2026-04-08 | Filing | |
| $37.77 | 3,961 | $149,606.97 | 112,018 | 2026-03-16 | Filing | |
| $37.11 | 5,950 | $220,804.50 | 115,979 | 2026-03-16 | Filing | |
| $37.77 | 4,241 | $160,182.57 | 137,101 | 2026-03-16 | Filing | |
| $37.11 | 6,371 | $236,427.81 | 141,342 | 2026-03-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,759,799 | $572,395,895 | 0.03% | |
| 2. | 8,478,815 | $307,950,573 | 0.01% | |
| 3. | 8,157,204 | $296,269,650 | 0.06% | |
| 4. | 4,673,935 | $169,757,319 | 0% | |
| 5. | 4,638,511 | $168,470,720 | 0% |
News See All
10 Under-the-Radar Stocks with Massive Upside for 2026
The benchmark 10-year Treasury yield hit its highest level since January 2025 that same week, while the 30-year yield briefly touched its highest since 2007, Reuters reported.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2026 Earnings Call Transcript
Operator: Hello, everyone. Thank you for joining us, and welcome to the Crinetics Pharmaceuticals First Quarter 2026 Financial Results.
Billionaire Tom Steyer's 10 Stock Picks with Huge Upside Potential
Tom Steyer, the billionaire investor and founder of Farallon Capital, has undergone a profound evolution from a pioneer of absolute-return hedge fund strategies to a leading architect of climate capitalism...
10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2025 Earnings Call Transcript
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2025 Earnings Call Transcript February 26, 2026Crinetics Pharmaceuticals, Inc. beats earnings expectations.
Analysts Bullish on Crinetics (CRNX) Amid Positive Clinical Trial for New Drug
Crinetics Pharmaceuticals Inc. (NASDAQ:CRNX) is one of the 13 hot stocks to buy with the highest upside potential. On January 30, Stifel raised its price target on Crinetics Pharmaceuticals Inc.
13 Hot Stocks to Buy with the Highest Upside Potential
On average, equities are expected continue to deliver positive results in 2026, this time with greater breadth across sectors, styles, and regions, compared to the other periods of the recent bull market...
Jim Cramer Recently Looked at These 25 Stocks
We're in critical short supply for all sorts of chips that are needed in the data center... It wasn't easy to forecast this boom, I admit, as recently as one year ago.
Goldman Sachs Upgrades Crinetics Pharmaceuticals, Inc. (CRNX) To Buy From Neutral
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is among the 14 best booming stocks to buy right now.
Hedge Fund Resource Center